MedTech News
.................... by Andrew Celentano
Breast tumors use sugar coating to evade immunity, opening potential immunotherapy path
An international research team led by the Medical University of Vienna has now identified a previously underestimated mechanism by which breast tumors evade the immune system.
Smartwatch seizure app spots 98% of tonic-clonic seizures, cuts false alarms
In people with epilepsy, a new study has found a smartwatch application accurately detected tonic-clonic seizures, seizures with major convulsions, with a low rate of false alarms. The study was published in Neurology Open Access.
Simple blood test could lead to personalized lung cancer treatment
A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, researchers have found. University of Queensland-led research focused on non-small cell lung cancer (NSCLC), the most common form of the disease, and showed how analyzing proteins in a blood sample could support earlier and better-informed treatment decisions.
New urine test may spot autism risk in children ages two to 11, study finds
The research, published in Molecular Psychiatry, points to a consistent biological pattern in many children with autism—elevated levels of specific metabolites in the gut.
Novel blood test detects rejection after lung transplant
A simple blood test could one day replace invasive biopsies for detecting acute cellular rejection (ACR) after lung transplantation, an American Journal of Transplantation study finds.
Living bandage accelerates healing across multiple wound types
Researchers at Rice University with the support of the Rice Biotech Launch Pad have developed a cytokine factory patch designed to address this challenge by continuously producing and delivering therapeutic cytokines directly within the wound environment.
AI maps brain waste-clearing flow, revealing two speeds tied to deep sleep
Kelley and his colleagues from the University of Rochester, Brown University, and the University of Copenhagen turned to artificial intelligence for help.
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test
SINGAPORE, May 27, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi-omic blood test designed to detect cancer-associated signals.